[Na +  + K + -activated transport-ATPase in experimental, cobalt chloride-induced heart insufficiency].
D000251:Adenosine Triphosphatases / Q000378:metabolism*; D000311:Adrenal Glands / Q000187:drug effects; D000315:Adrenalectomy; D000818:Animals; D001692:Biological Transport; D002712:Chlorides; D003035:Cobalt / Q000009:adverse effects; D004721:Endoplasmic Reticulum / Q000187:drug effects; D004789:Enzyme Activation; D006321:Heart / Q000187:drug effects; D006331:Heart Diseases / Q000139:chemically induced / Q000201:enzymology*; D007668:Kidney / Q000201:enzymology; D008797:Metyrapone / Q000494:pharmacology; D009206:Myocardium / Q000201:enzymology; D011188:Potassium / Q000502:physiology; D051381:Rats; D012964:Sodium / Q000502:physiology
D002712:Chlorides; D003035:Cobalt; D012964:Sodium; D000251:Adenosine Triphosphatases; D011188:Potassium; D008797:Metyrapone
Die Na +  + K + -aktivierte Transport-ATPase bei experimenteller Herzinsuffizienz durch Kobaltchlorid.